Ampio Pharmaceuticals
AMPE
$0.21
Share price
-0.94%
Change (1 day)
-25.00%
Change (1 year)
Categories
Ampio Pharmaceuticals (AMPE) - Total debt
Total debt on the balance sheet as of December 2023 : $0.27 M
According to Ampio Pharmaceuticals's latest financial reports the company's total debt is $0.27 M. A company’s total debt is the sum of all current and non-current debts.
Ampio Pharmaceuticals - Total debt on balance sheet (from 2007 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.61 M | -33.62% |
| 2021-12-31 | $0.92 M | -23.49% |
| 2020-12-31 | $1.2 M | -17.7% |
| 2019-12-31 | $1.46 M | 173.56% |
| 2018-12-31 | $0.53 M | |
| 2015-12-31 | $4.92 M | |
| 2010-12-31 | $2.13 M | |
| 2007-12-31 | $0.02 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 12,274,352.55% | 🇺🇸 USA |
 Pfizer PFE | $68.70 B | 25,075,812.41% | 🇺🇸 USA |
 Abbott Laboratories ABT | $14.58 B | 5,323,257.66% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $2.70 B | 986,505.84% | 🇺🇸 USA |
 Rigel Pharmaceuticals RIGL | $60.49 M | 21,979.93% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.33 B | 122,887.59% | 🇺🇸 USA |